Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients.
Fiche publication
Date publication
mai 2022
Journal
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Auteurs
Membres identifiés du Cancéropôle Est :
Dr QUIPOURT Valérie, Dr BENGRINE-LEFEVRE Leila, Pr SCHMITT Antonin
Tous les auteurs :
Lory P, Perche L, Blanc J, Fouquier B, Giroux A, Thomassin A, Devaux M, Renaudin A, Di Martino C, Quipourt V, Bengrine-Lefèvre L, Schmitt A
Lien Pubmed
Résumé
The use of oral anti-cancer therapies is becoming increasingly common in the management of cancers, raising the question of adherence. The objective of this study was to assess adherence to oral anti-cancer therapies, as well as the impact of various factors that may influence it.
Mots clés
Adherence, cytotoxic, oral anti-cancer therapy, pharmaceutical consultation, tyrosine kinase inhibitor
Référence
J Oncol Pharm Pract. 2022 05 29;:10781552221103547